Alpha Profiles · Company Profile

GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies.

https://registry.alpha.ac/companies/geovax-labs-inc

Entity: Public listing published
Primary listing: NASDAQ: GOVX
Verification: Partially verified
Last reviewed: 2026-10-17T04:47:26.644376+00:00

Overview

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

David A. Dodd

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-26-013468Apr 27, 2026

John W. Sharkey

Vice President, Business Development

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-26-013468Apr 27, 2026

Kelly T. McKee

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-26-013468Apr 27, 2026

Mark J. Newman

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-26-013468Apr 27, 2026

Mark W. Reynolds

Chief Financial Officer and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-26-013468Apr 27, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.